DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Virtual Booth

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: Medullin, Pga2, 13345-50-1, (+)-prostaglandin a2, 5,6-cis-pga2, (15s)-pga2

Molecular Formula

C₂₀H₃₀O₄

Molecular Weight

334.4 g/mol

InChI Key

MYHXHCUNDDAEOZ-FOSBLDSVSA-N

FDA UNII

K6VT5BDY9E

prostaglandin A2 is a natural product found in Plexaura homomalla, Larix sibirica, and other organisms with data available.

1 2D Structure

Prostaglandin A2

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

(Z)-7-[(1R,2S)-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopent-3-en-1-yl]hept-5-enoic acid

2.1.2 InChI

InChI=1S/C20H30O4/c1-2-3-6-9-17(21)14-12-16-13-15-19(22)18(16)10-7-4-5-8-11-20(23)24/h4,7,12-18,21H,2-3,5-6,8-11H2,1H3,(H,23,24)/b7-4-,14-12+/t16-,17-,18+/m0/s1

2.1.3 InChI Key

MYHXHCUNDDAEOZ-FOSBLDSVSA-N

2.1.4 Canonical SMILES

CCCCCC(C=CC1C=CC(=O)C1CC=CCCCC(=O)O)O

2.1.5 Isomeric SMILES

CCCCC[C@@H](/C=C/[C@H]1C=CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O

2.2 Other Identifiers

2.2.1 UNII

K6VT5BDY9E

2.3 Synonyms

2.3.1 MeSH Synonyms

1. (+)-prostaglandin A2

2. (5z,13e,15s)-15-hydroxy-9-oxoprosta-5, 10,13-triene-1-oic Acid

3. (z)-7-((1r,2s)-2-((e)-(3s)-3-hydroxyoct-1-enyl)-5-oxocyclopent-3-enyl)hept-5-enoic Acid

4. Medullin

5. Pga2

2.3.2 Depositor-Supplied Synonyms

1. Medullin

2. Pga2

3. 13345-50-1

4. (+)-prostaglandin A2

5. 5,6-cis-pga2

6. (15s)-pga2

7. (+)-prostaglandin A(sup 2)

8. K6vt5bdy9e

9. 15(s)-prostaglandin A2

10. Chebi:27820

11. Prosta-5,10,13-trien-1-oic Acid, 15-hydroxy-9-oxo-, (5z,13e,15s)-

12. 9-oxo-15s-hydroxy-5z,10z,13e-prostatrienoic Acid

13. (z)-7-[(1r,2s)-2-[(e,3s)-3-hydroxyoct-1-enyl]-5-oxocyclopent-3-en-1-yl]hept-5-enoic Acid

14. 15(s)-hydroxy-9-oxo-5-cis-10,13-trans-prostatrienoic Acid

15. Nsc 165561

16. Pga2 (prostaglandin A2)

17. 15(s)-hydroxy-9-oxo-5-cis-10,13-trans-prostenoic Acid

18. Pga(sup 2)

19. Prosta-5,10,13-trien-1-oicacid, 15-hydroxy-9-oxo-, (5z,13e,15s)-

20. 5,6-cis-pga(sup 2)

21. Mls000069589

22. Prostaglandin A(sup 2)

23. Unii-k6vt5bdy9e

24. (155)-pga2

25. Brn 2221844

26. Nsc-165561

27. (~{z})-7-[(1~{r},5~{s})-2-oxidanylidene-5-[(~{e},3~{s})-3-oxidanyloct-1-enyl]cyclopent-3-en-1-yl]hept-5-enoic Acid

28. Smr000058790

29. Pga2(prostaglandin A2)

30. Bspbio_001460

31. Bml1-f02

32. Gtpl6279

33. Schembl2115595

34. Chembl1084643

35. Dtxsid20864388

36. Prostaglandin A2 (pga2)

37. Hms1361i22

38. Hms1791i22

39. Hms1989i22

40. Hms3402i22

41. Hms3648i11

42. Zinc4521813

43. (5z,13e,15s)-15-hydroxy-9-oxoprosta-5, 10,13-triene-1-oic Acid

44. (5z,13e,15s)-15-hydroxy-9-oxoprosta-5,10,13-trien-1-oic Acid

45. Lmfa03010035

46. Prosta-5,10-13-trien-1-oic Acid, 15-hydroxy-9-oxo-, (5z,13e,15s)-

47. (z)-7-((1r,2s)-2-((e)-(3s)-3-hydroxyoct-1-enyl)-5-oxocyclopent-3-enyl)hept-5-enoic Acid

48. 5-heptenoic Acid, 7-(2-(3-hydroxy-1-octenyl)-5-oxo-3-cyclopenten-1-yl)- (van)

49. Idi1_033930

50. Ncgc00022061-03

51. Ncgc00022061-04

52. Ncgc00022061-05

53. Hy-113041

54. Cs-0059420

55. Dinoprostone Impurity D [ep Impurity]

56. C05953

57. Sr-01000946222

58. Sr-01000946222-1

59. 15(s)-hydroxy-9-oxo-5-cis-10,13-trans-prostenoate

60. Brd-k34782918-001-02-5

61. Q27088462

62. 15a-hydroxy-9-oxo-cis-5,10,trans-13-prostatrienoate

63. 15(s)-hydroxy-9-oxo-5-cis-10,13-trans-prostatrienoate

64. 15a-hydroxy-9-oxo-cis-5,10,trans-13-prostatrienoic Acid

65. 15a-hydroxy-9-oxo-cis-5,10,trans-13-prostatrienecarboxylate

66. 362927f3-3a3e-47bc-84c3-c32a293aa956

67. 15.alpha.-hydroxy-9-oxo-cis-5,10,trans-13-prostatrienoic Acid

68. 15a-hydroxy-9-oxo-cis-5,10,trans-13-prostatrienecarboxylic Acid

69. 15.alpha.-hydroxy-9-oxo-cis-5,10,trans-13-prostatrienecarboxylic Acid

70. (z)-7-[(1r,2s)-2-[(e,3s)-3-hydroxyoct-1-enyl]-5-oxo-1-cyclopent-3-enyl]hept-5-enoic Acid

71. (z)-7-[(1r,2s)-2-[(e,3s)-3-hydroxyoct-1-enyl]-5-oxo-cyclopent-3-en-1-yl]hept-5-enoic Acid

72. Dinoprostone Impurity, (5z,13e,15s)-15-hydroxy-9-oxoprosta-5, 10,13-triene-1-oic Acid- [usp Impurity]

2.4 Create Date

2005-06-24

3 Chemical and Physical Properties

Molecular Formula	C₂₀H₃₀O₄
Molecular Weight	334.4 g/mol
XLogP3	3.6
Hydrogen Bond Donor Count	2
Hydrogen Bond Acceptor Count	4
Rotatable Bond Count	12
Exact Mass	334.21440943 g/mol
Monoisotopic Mass	334.21440943 g/mol
Topological Polar Surface Area	74.6 Å²
Heavy Atom Count	24
Formal Charge	0
Complexity	476
Isotope Atom Count	0
Defined Atom Stereocenter Count	3
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	2
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

ABOUT THIS PAGE

Find Prostaglandin A2 manufacturers, exporters & distributors on PharmaCompass

Prostaglandin A2

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

PATENTS & EXCLUSIVITIES

DIGITAL CONTENT

GLOBAL SALES INFORMATION

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

What are you looking for?